Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-291-8 | CAS number: 13282-70-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2014-10-17 to 2015-02-26
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- up-and-down procedure
- Limit test:
- no
Test material
- Reference substance name:
- N-[3-(dimethylamino)propyl]stearamide monoacetate
- EC Number:
- 236-291-8
- EC Name:
- N-[3-(dimethylamino)propyl]stearamide monoacetate
- Cas Number:
- 13282-70-7
- Molecular formula:
- C23H48N2O.C2H4O2
- IUPAC Name:
- N-[3-(dimethylamino)propyl]stearamide monoacetate
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Remarks:
- CRL
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Rationale for alternative/additional species to rat (if applicable): based on consistently acceptable health status and on extensive experience with the strain at DuPont Haskell.
- Source: Charles River Laboratories International, Inc., Raleigh, North Carolina, U.S.A.
- Females (if applicable) nulliparous and non-pregnant: [yes]
- Rationale for use of males (if applicable):n/a
- Age at study initiation: 8-11 weeks old on the day of dosing.
- Weight at study initiation: n/a
- Fasting period before study: 16-18 hours prior to dosing.
- Housing:individually in solid-bottom caging with bedding and appropriate species- specific enrichment.
- Historical data:n/a
- Diet (e.g. ad libitum): PMI® Nutrition International, LLC Certified Rodent LabDiet® 5002, ad libitum.
- Water (e.g. ad libitum):ad libitum except as noted in section E. Dosing.
- Acclimation period:6-day quarantine period.
- Microbiological status when known: Water samples are analyzed for total bacterial counts, and the presence of coliforms, lead, and other contaminants. Samples from freshly washed cages and cage racks are analyzed to ensure adequate sanitation by the cagewashers.
- Method of randomisation in assigning animals to test and control groups: A software package (AOT425StatPgm)a was used to determine the dose progression.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-26°C
- Humidity (%): 30-70%
- Air changes (per hr): n/a
- Photoperiod (hrs dark / hrs light): Animal rooms were artificially illuminated (fluorescent light) on an approximate 12-hour light/dark cycle.
IN-LIFE DATES: From:21 October 2014 To: 3 December 2014
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- 0.1% Tween 80 (V/V) in deionized water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle:(1:1)
- Amount of vehicle (if gavage):0.1%
- Justification for choice of vehicle:n/a
- Lot/batch no. (if required): n/a
- Purity: n/a
- Doses:
- 175, 550, 1750, 5000, and 2000 mg/kg.
The rats were dosed at a volume of 10, 17.5, 20, or 40 mL per kg of body weight. - Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:daily observation and weighted on days -1,1,8 and 15 or on the day of the sacrifice.
- Necropsy of survivors performed: yes
- Clinical signs including body weight: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other:n/a
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 403 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All animals dosed at 5000 or 2000 mg/kg died within a day after dosing
- Clinical signs:
- diarrhoea
- Body weight:
- other body weight observations
- Gross pathology:
- Gross findings were present in 4 female rats; 2 found dead and 2 sacrificed prior to scheduled sacrifice. The 2 found dead rats were administered 2000 mg/kg and had brown/green staining of the skin of the perineum. Of the 2 rats sacrificed prior to scheduled sacrifice, one was administered 2000 mg/kg and had brown staining about the perineum, yellow/clear fluid in the small intestine and cecum as well as whole body thinness (presumed dehydration). The other rat was administered 5000 mg/kg and had brown staining of the skin of the perineum. These observations are non-specific and not indicative of target organ toxicity. No other gross findings were observed.
- Other findings:
- - 5000 or 2000 mg/kg groups, preceding death.:
cold to touch, dehydration, eyelid ptosis, hunched posture, hypoactive, moribund status, decreased muscle tone, pale, high posture, prostrate, soiled skin or fur, and wet fur.
- At 1750 mg/kg:
diarrhea, soiled skin or fur, and wet fur between test days 2 and 3.
- At 550 mg/kg:
diarrhea and soiled skin or fur in 2/3 animals between test days 1 and 3.
Any other information on results incl. tables
Test Sequence |
Group ID |
Dose (mg/kg) |
Short-term Result |
Long-term Result |
1 |
1 |
175 |
O |
O |
2 |
2 |
550 |
O |
O |
3 |
3 |
1750 |
O |
O |
4 |
4 |
5000 |
X |
X |
5 |
5 |
2000 |
X |
X |
6 |
6 |
550 |
O |
O |
7 |
7 |
2000 |
X |
X |
8 |
8 |
550 |
O |
O |
9 |
9 |
2000 |
X |
X |
X Died
O Survived
Summary of Long-Term Results
Dose (mg/kg) |
O |
X |
Total |
175 |
1 |
0 |
1 |
550 |
3 |
0 |
3 |
1750 |
1 |
0 |
1 |
2000 |
0 |
3 |
3 |
5000 |
0 |
1 |
1 |
All Doses |
5 |
4 |
9 |
Statistical Estimate based on long term outcomes: the LD50 is 1403 mg/kg.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- Under the conditions of this study, the oral LD50 for H-31339 was 1403 mg/kg for female rats.
According to the United Nations Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Fifth revised edition 2013, H-31339 is classified in Category 4. - Executive summary:
H-31139 was administered by oral gavage to fasted female rats at a dose of 175, 550, 1750, 5000, or 2000 mg/kg. The rats were dosed one at a time at approximately 48-hour intervals. All rats were observed for mortality, body weight effects, and clinical signs for 14 days after dosing. The rats were necropsied to detect grossly observable evidence of organ or tissue damage.
All animals dosed at 5000 or 2000 mg/kg died within a day after dosing; clinical abnormalities preceding death included abnormal gait, cold to touch, dehydration, diarrhea, eyelid ptosis, hunched posture, hypoactive, moribund status, decreased muscle tone, pallor, high posture, prostrate, salivation, soiled skin or fur, and wet fur. At 1750 mg/kg, there were no incidents of mortality or overall body weight losses; clinical abnormalities included diarrhea, soiled skin or fur, and wet fur between test days 2 and 3. At 550 mg/kg, there were no incidents of mortality or overall body weight losses; clinical abnormalities included diarrhea and soiled skin or fur in 2/3 animals between test days 1 and 3. At 175 mg/kg there were no incidents of mortality, overall body weight losses, or clinical abnormalities.
Gross findings were present in 4 female rats; 2 found dead and 2 sacrificed prior to scheduled sacrifice. The 2 found dead rats were administered 2000 mg/kg and had brown/green staining of the skin of the perineum. Of the 2 rats sacrificed prior to scheduled sacrifice, one was administered 2000 mg/kg and had brown staining about the perineum, yellow/clear fluid in the small intestine and cecum as well as whole body thinness (presumed dehydration). The other rat was administered 5000 mg/kg and had brown staining of the skin of the perineum. These observations are non-specific and not indicative of target organ toxicity. No other gross findings were observed.
Under the conditions of this study, the oral LD50 for H-31339 was 1403 mg/kg for female rats.
In accordance with the provisions of Directive 67/548/EEC amended by COMMISSION DIRECTIVE 2001/59/EC of 6 August 2001, Annex VI, H-31339 is assigned the symbol “Xn” and the risk phrase “Harmful if swallowed.”
According to the United Nations Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Fifth revised edition 2013, H-31339 is classified in Category 4.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.